SITC Cancer Immunotherapy CONNECT

Browse our other events


Immunotherapy

Advances in Cancer Immunotherapy™ (ACI) Series

ACI programs are certified for CME, CNE, CPE, and MOC credits. ACI's offer in-depth clinical training in immunotherapy treatment for a variety of disease states and topics. ACI webinars are FREE for healthcare professionals, students, patients and patient advocates.

Explore the 2024 ACI Series
ACI Intratumoral Therapies, Vaccines and Cytokines

Advances in Cancer Immunotherapy™: A Focus on Intratumoral Therapies, Vaccines, & Cytokines

Wednesday, Oct. 9 | 11 a.m.–3 p.m. ET Virtual – Zoom

Program features a session on emerging therapies, where the EMERALD trial and FLASH radiotherapy plan to be discussed. 

Explore Program
AI in IO: SITC-NCI Computational Immuno-oncology Webinar Series

Rationalized Patient Match and Clinical Trial Design with Large/Moderate Language Models on EHR Data: AI in IO Webinar

Tuesday, Oct. 15 | 1–2 p.m. ET | Virtual

Learn how advances in AI application are used to analyze EHR data to better design immunotherapy clinical trials and efficiently match potential patients.

Register for FREE
Increasing Access to IO: A Global Webinar Series

Monitoring Response to Immunotherapy (iRECIST): Increasing Access to IO Webinar

Wednesday, Oct. 16 | 12–1:30 p.m. EDT

This webinar will examine the importance of assessing tumor response to immunotherapy with currently available tools, primarily iRECIST, and how they compare to RECIST and WHO criteria.

Register for FREE
Targets for Cancer IO: A Deep Dive Series

Targets for Cancer IO: A Deep Dive into the Role of Neutrophils in Anti-tumor Immunity Webinar

Wed., Oct. 23 | 12–2 p.m. ET | Virtual

Leading experts in the field will provide an overview of the current state of the science and address questions about its future. An interactive Q&A session will follow the topic overview of this webinar.

.

Learn more & Register
ACI Pathology

Advances in Cancer Immunotherapy™: A Focus on Pathology

Tuesday, Dec. 10 |11 a.m.–3 p.m. ET Virtual – Zoom

Join SITC and a panel of experts for an afternoon of in-depth education on all aspects of the clinical implementation of immuno-oncology pathology.

REGISTER
2025 Winter School

2025 Cancer Immunotherapy Winter School

February 11–14, 2025 in Austin, TX
and Virtually

Explore the core principles of tumor immunology and cancer immunotherapy, including biomarker technology, validation and clinical integration, clinical trial design, data analysis and considerations for combination therapies.

Register Today
Sparkathon 2025

SITC Sparkathon Class of 2025: Cellular Therapy for Solid Tumors

March 10–12, 2025 in San Diego, CA

This impactful program brings together early career investigators with established leaders in cancer immunotherapy to foster leadership development, collaborations and scientific exchange

Apply Today
2025 Spring Scientific

2025 Spring Scientific: Cellular Therapy for Solid Tumors

March 12–14, 2025 in San Diego, CA
& Virtually

SITC will bring the brightest minds and the next generation of leaders together to explore promising science and develop novel opportunities to challenges that impede bringing these novel therapies to patients in need.

Register Today

Making Cure a Reality

The Society for Immunotherapy of Cancer (SITC) is the world’s leading member-driven society dedicated to professionals working in the field of cancer immunotherapy.

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.

Learn More

 Upcoming SITC Events


 Read the Latest SITC News

This webinar on September 26th examined how rare and challenging cases, such as extremes of ...
In cooperation with the Food and Drug Administration (FDA), and as a service to our members, ...
Increased understanding of immunotherapy mechanisms of action may enhance researchers’ ability ...

 Latest Discussions

  • The abstract submission site is NOW OPEN for 2025 SITC Spring Scientific ...

  • 2024 IOTOX Symposium

    The MD Anderson Internal Medicine Division and Cancer Medicine Division are ...

  • Hello! SITC is pleased to host the SITC Summit on Intralesional Immunotherapy: ...

    1 person likes this.

JITC Logo

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Read the Journal

 Join the SITC Family